BCL2L1 and breast cancer: Given that Bcl‐xL is a signature molecule of mitochondrial apoptosis [30], we propose that FLLL31 triggers mitochondria‐dependent apoptosis in BC cells via a FOXO4‐mediated upregulation of BCL6, culminating in the repression of the antiapoptotic factor Bcl‐xL.